Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › SC › Florence › NPI 1184197683
Hospital

Medical University Hospital Authority

Medical University Hospital Authority was paid $28.25M by Medicaid between Feb 2019 and Dec 2024, across 337 billing codes. Its largest line is 80053, Comprehensive metabolic panel — 12% of everything it billed.

33Billing provider infoMEDICAL UNIVERSITY HOSPITAL AUTHORITY
FLORENCE, SC 29505
33aNPI1184197683assigned 01/07/2019
33bProvider typeGeneral Acute Care Hospital
28Total paid$28.25M
24GClaims786,447
24DCodes billed337
24AFirst – last monthFeb 2019 – Dec 2024
Compared with peers

Next to other General Acute Care Hospital providers in South Carolina

Rank by total paid#10 of 115
Median peer was paid$2.47M
This provider vs. median11×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official RAE, KARYN controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$200K$400K$600K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201991,550$3.62M
202093,086$4.02M
2021135,026$5.42M
2022181,141$5.90M
2023151,853$5.13M
2024incomplete133,791$4.16M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
80053 Comprehensive metabolic panel 12% 30,417 25,391 $3.26M
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml 6.7% 13,125 9,184 $1.88M
99282 Emergency department visit for the evaluation and management, low to moderate severity 6.4% 15,014 13,556 $1.79M
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm 5.1% 1,943 1,200 $1.43M
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 4.8% 11,485 9,333 $1.37M
A9585 Injection, gadobutrol, 0.1 ml 4.8% 1,421 1,255 $1.37M
80048 Basic metabolic panel (calcium, ionized) 4.4% 18,821 14,742 $1.25M
96367 2.8% 1,791 1,207 $789K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 2.5% 8,342 7,973 $693K
36415 Collection of venous blood by venipuncture 2.4% 43,125 31,246 $690K
96375 Therapeutic injection; each additional sequential IV push 2.2% 9,806 7,374 $634K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 2.1% 27,182 24,959 $587K
325 more codes
80047 1.9% 10,238 $550K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r 1.7% 4,765 $483K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 1.6% 13,141 $440K
A9552 Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries 1.5% 327 $417K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance 1.4% 3,028 $391K
86850 1.4% 4,024 $388K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.4% 5,190 $383K
81001 1.3% 18,305 $380K
82947 1.3% 8,404 $369K
96361 Intravenous infusion, hydration; each additional hour 1.3% 4,589 $364K
78452 Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress 1.2% 1,772 $334K
81025 1.2% 5,882 $327K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.1% 3,831 $305K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 2,954 $207K
84702 <1% 3,130 $191K
71250 <1% 1,262 $183K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 721 $180K
83735 <1% 15,072 $175K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 46,725 $166K
86900 <1% 4,798 $163K
59025 Fetal non-stress test <1% 4,357 $163K
99284 Emergency room visit (serious) <1% 18,259 $151K
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 2,986 $148K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 2,038 $147K
82565 <1% 1,167 $144K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 3,661 $136K
70450 Computed tomography, head or brain; without contrast material <1% 4,638 $127K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type <1% 2,714 $124K
85610 <1% 5,717 $121K
87081 <1% 1,114 $118K
99213 Doctor's office visit, returning patient (routine) <1% 3,300 $113K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 409 $109K
71046 Radiologic examination, chest; 2 views <1% 4,981 $104K
87070 <1% 718 $100K
73630 <1% 1,322 $99K
85027 <1% 11,822 $95K
77063 Screening digital breast tomosynthesis, bilateral <1% 952 $90K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 2,582 $90K
81003 <1% 5,568 $89K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 10,317 $88K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,918 $88K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 4,963 $88K
71045 Radiologic examination, chest; single view <1% 11,457 $88K
J2704 Injection, propofol, 10 mg <1% 8,910 $83K
72040 <1% 1,040 $78K
87210 <1% 1,093 $77K
82570 <1% 2,624 $76K
88342 <1% 704 $76K
A9579 Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml <1% 122 $75K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 17,052 $74K
77336 <1% 206 $74K
G0378 Hospital observation service, per hour <1% 10,073 $73K
73030 <1% 1,338 $72K
88304 <1% 830 $72K
94010 <1% 302 $72K
87807 <1% 1,212 $72K
81002 <1% 627 $71K
72100 <1% 1,688 $71K
93971 <1% 542 $67K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 1,702 $66K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 1,686 $65K
10060 <1% 96 $64K
73610 <1% 838 $63K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 1,391 $59K
80076 <1% 2,696 $55K
73560 <1% 1,174 $55K
82728 <1% 2,094 $52K
74018 <1% 1,346 $50K
73130 <1% 557 $49K
84156 <1% 1,741 $48K
99285 Emergency room visit (most serious) <1% 7,707 $47K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 17,717 $46K
95811 <1% 251 $46K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 1,339 $46K
93017 <1% 1,995 $44K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,474 $44K
80061 Lipid panel <1% 7,956 $43K
0002A <1% 809 $43K
96376 <1% 3,779 $42K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 4,860 $42K
95813 <1% 151 $41K
82962 <1% 329 $40K
0001A <1% 740 $38K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 3,669 $37K
82607 <1% 2,495 $37K
70551 Magnetic resonance imaging, brain; without contrast material <1% 239 $36K
87077 <1% 2,147 $35K
84439 <1% 3,997 $32K
77067 Screening mammography, bilateral, including computer-aided detection <1% 1,486 $30K
84484 <1% 14,904 $27K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 150 $24K
83036 Hemoglobin; glycosylated (A1C) <1% 6,812 $24K
84153 <1% 464 $22K
84443 Thyroid stimulating hormone (TSH) <1% 9,271 $20K
84132 <1% 1,237 $20K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 156 $19K
76700 Ultrasound, abdominal, real time with image documentation; complete <1% 211 $18K
74022 <1% 1,009 $18K
86140 <1% 2,184 $17K
74177 Computed tomography, abdomen and pelvis; with contrast material <1% 4,677 $17K
87420 <1% 151 $16K
0012A <1% 238 $16K
95700 <1% 116 $15K
72125 Computed tomography, cervical spine; without contrast material <1% 762 $15K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 82 $15K
78815 Positron emission tomography (PET) for limited area imaging <1% 385 $14K
86710 <1% 181 $14K
73110 <1% 206 $14K
C9113 Injection, pantoprazole sodium, per vial <1% 1,731 $14K
83880 <1% 4,015 $13K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) <1% 242 $13K
J2270 Injection, morphine sulfate, up to 10 mg <1% 4,500 $13K
97161 <1% 1,864 $13K
97535 Self-care/home management training, each 15 minutes <1% 1,387 $12K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 2,530 $12K
43235 <1% 425 $11K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 812 $11K
76770 <1% 181 $11K
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 3,218 $11K
95800 <1% 66 $11K
83605 <1% 5,224 $10K
J1170 Injection, hydromorphone, up to 4 mg <1% 8,665 $10K
97116 <1% 1,832 $10K
73502 <1% 300 $10K
J1644 Injection, heparin sodium, per 1000 units <1% 1,803 $10K
45378 Colonoscopy, flexible; diagnostic, including collection of specimen(s) <1% 140 $9K
97597 <1% 213 $9K
80197 <1% 1,031 $9K
85730 <1% 3,487 $8K
72148 Magnetic resonance imaging, lumbar spine; without contrast material <1% 31 $8K
J3010 Injection, fentanyl citrate, 0.1 mg <1% 6,944 $8K
93880 <1% 158 $8K
94726 <1% 227 $8K
99214 Doctor's office visit, returning patient (more involved) <1% 475 $7K
85379 <1% 2,435 $7K
76815 Ultrasound, pregnant uterus, real time with image documentation, limited <1% 82 $7K
A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose <1% 1,639 $7K
73562 <1% 201 $7K
87040 <1% 3,677 $7K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 2,331 $7K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 122 $6K
82330 <1% 510 $6K
82550 <1% 1,902 $6K
J1650 Injection, enoxaparin sodium, 10 mg <1% 1,771 $6K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 7,056 $6K
76801 <1% 153 $6K
J2785 Injection, regadenoson, 0.1 mg <1% 1,442 $6K
73590 <1% 142 $6K
86780 <1% 512 $6K
78227 <1% 41 $6K
0003A <1% 111 $6K
82803 <1% 806 $5K
A9609 Fludeoxyglucose f18 up to 15 millicuries <1% 14 $5K
T5999 Supply, not otherwise specified <1% 40 $5K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel <1% 72 $5K
72141 <1% 14 $5K
77300 <1% 16 $5K
83021 <1% 85 $4K
C1758 Catheter, ureteral <1% 278 $4K
83690 <1% 8,212 $4K
0011A <1% 72 $4K
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 5,790 $4K
J3475 Injection, magnesium sulfate, per 500 mg <1% 1,391 $4K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward <1% 87 $4K
84550 <1% 900 $4K
J2550 Injection, promethazine hcl, up to 50 mg <1% 1,980 $3K
87205 <1% 388 $3K
85014 <1% 927 $3K
J3480 Injection, potassium chloride, per 2 meq <1% 678 $3K
82248 <1% 2,074 $3K
83540 <1% 2,199 $3K
86592 <1% 496 $3K
76830 Ultrasound, transvaginal <1% 22 $3K
72070 <1% 91 $3K
82043 <1% 940 $3K
76536 <1% 43 $3K
73564 <1% 26 $3K
J0690 Injection, cefazolin sodium, 500 mg <1% 3,862 $3K
0071A <1% 51 $3K
78226 <1% 13 $3K
84145 <1% 924 $3K
J2370 Injection, phenylephrine hcl, up to 1 ml <1% 1,017 $3K
0072A <1% 49 $3K
J2060 Injection, lorazepam, 2 mg <1% 1,246 $3K
86762 <1% 178 $3K
95816 <1% 28 $3K
84100 <1% 2,234 $2K
93922 <1% 15 $2K
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 55 $2K
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 645 $2K
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 3,616 $2K
93970 <1% 41 $2K
M0243 Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring <1% 59 $2K
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg <1% 877 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 52 $2K
99215 Doctor's office visit, returning patient (complex) <1% 73 $2K
86803 <1% 79 $2K
76642 <1% 60 $2K
87340 <1% 215 $2K
76819 Fetal biophysical profile; without non-stress testing <1% 18 $2K
74420 <1% 548 $2K
80081 <1% 96 $2K
74019 <1% 44 $2K
85007 <1% 190 $2K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 500 $1K
Q9963 High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml <1% 72 $1K
J3370 Injection, vancomycin hcl, 500 mg <1% 33 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 36 $1K
97162 <1% 93 $1K
82784 <1% 42 $1K
0053A <1% 33 $1K
J1940 Injection, furosemide, up to 20 mg <1% 575 $1K
76816 Ultrasound, pregnant uterus, real time with image documentation, follow-up <1% 12 $1K
70486 <1% 52 $1K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 1,334 $1K
71275 Computed tomographic angiography, chest, with contrast material <1% 59 $1K
J0330 Injection, succinylcholine chloride, up to 20 mg <1% 1,016 $959.73
97112 Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination <1% 218 $917.08
76641 <1% 15 $905.15
83615 <1% 421 $887.08
M0239 Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring <1% 17 $824.72
92526 <1% 21 $814.67
82951 <1% 448 $793.63
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 75 $753.26
82150 <1% 198 $674.74
87899 <1% 50 $607.32
82105 <1% 78 $540.66
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 1,656 $524.41
85652 <1% 2,328 $522.25
45380 Colonoscopy, flexible; with biopsy, single or multiple <1% 492 $470.82
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 9,189 $447.33
73070 <1% 14 $412.66
95713 <1% 77 $393.51
80164 <1% 152 $379.43
82746 <1% 1,311 $375.51
97165 <1% 303 $373.37
Q0162 Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen <1% 342 $360.38
84146 <1% 47 $324.81
84155 <1% 12 $308.93
87186 <1% 1,539 $266.39
86038 <1% 55 $230.24
82140 <1% 113 $228.31
0124A <1% 19 $225.53
80320 <1% 805 $164.88
86706 <1% 13 $163.77
83970 <1% 118 $136.73
80329 <1% 147 $130.96
85018 <1% 458 $118.58
84295 <1% 648 $116.78
73552 <1% 12 $109.24
82374 <1% 13 $104.58
82952 <1% 496 $85.03
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 16 $64.90
84466 <1% 171 $62.44
85045 <1% 402 $47.54
M0247 Intravenous infusion, sotrovimab, includes infusion and post administration monitoring <1% 20 $33.19
84436 <1% 28 $32.03
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 484 $26.15
82077 <1% 561 $16.92
90715 <1% 326 $12.27
J1596 Injection, glycopyrrolate, 0.1 mg <1% 258 $8.60
C1725 Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) 0% 54 $0.00
93458 0% 458 $0.00
83550 0% 720 $0.00
C1769 Guide wire 0% 1,343 $0.00
86901 0% 4,102 $0.00
96415 0% 140 $0.00
87088 0% 278 $0.00
96368 0% 43 $0.00
99153 Mod sedat endo service >5yrs 0% 537 $0.00
J0360 Injection, hydralazine hcl, up to 20 mg 0% 560 $0.00
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units 0% 31 $0.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 0% 156 $0.00
J1630 Injection, haloperidol, up to 5 mg 0% 128 $0.00
G0481 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed 0% 126 $0.00
36430 0% 21 $0.00
J2371 Injection, phenylephrine hydrochloride, 20 micrograms 0% 477 $0.00
J2003 Injection, lidocaine hydrochloride, 1 mg 0% 203 $0.00
J7512 Prednisone, immediate release or delayed release, oral, 1 mg 0% 42 $0.00
90935 Hemodialysis procedure with single evaluation by a physician 0% 15 $0.00
Q0247 Injection, sotrovimab, 500 mg 0% 12 $0.00
J2795 Injection, ropivacaine hydrochloride, 1 mg 0% 23 $0.00
J2470 Injection, pantoprazole sodium, 40 mg 0% 19 $0.00
J3490 Unclassified drugs 0% 18 $0.00
J0461 Injection, atropine sulfate, 0.01 mg 0% 13 $0.00
94644 0% 34 $0.00
J2543 Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) 0% 30 $0.00
94760 0% 47 $0.00
52005 0% 13 $0.00
J1920 Injection, labetalol hydrochloride, 5 mg 0% 33 $0.00
J2305 Injection, nitroglycerin, 5 mg 0% 28 $0.00
99152 0% 1,264 $0.00
96417 0% 692 $0.00
J1756 Injection, iron sucrose, 1 mg 0% 115 $0.00
C1894 Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser 0% 1,147 $0.00
J0692 Injection, cefepime hydrochloride, 500 mg 0% 260 $0.00
J0780 Injection, prochlorperazine, up to 10 mg 0% 46 $0.00
J2710 Injection, neostigmine methylsulfate, up to 0.5 mg 0% 353 $0.00
J1453 Injection, fosaprepitant, 1 mg 0% 421 $0.00
Q0244 Injection, casirivimab and imdevimab, 1200 mg 0% 14 $0.00
J1643 Injection, heparin sodium (pfizer), not therapeutically equivalent to j1644, per 1000 units 0% 80 $0.00
80143 0% 40 $0.00
J2919 Injection, methylprednisolone sodium succinate, 5 mg 0% 172 $0.00
J2004 Injection, lidocaine hcl with epinephrine, 1 mg 0% 15 $0.00
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 535 $0.00
94729 0% 225 $0.00
C1887 Catheter, guiding (may include infusion/perfusion capability) 0% 88 $0.00
80179 0% 26 $0.00
84165 0% 29 $0.00
86923 0% 52 $0.00
J2274 Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg 0% 205 $0.00
36600 0% 301 $0.00
J1245 Injection, dipyridamole, per 10 mg 0% 102 $0.00
J0171 Injection, adrenalin, epinephrine, 0.1 mg 0% 28 $0.00
85046 0% 52 $0.00
Q0243 Injection, casirivimab and imdevimab, 2400 mg 0% 17 $0.00
92610 0% 13 $0.00
J1956 Injection, levofloxacin, 250 mg 0% 26 $0.00
C1760 Closure device, vascular (implantable/insertable) 0% 12 $0.00
Q0239 Injection, bamlanivimab-xxxx, 700 mg 0% 15 $0.00
G8979 Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting 0% 15 $0.00
J1171 Injection, hydromorphone, 0.1 mg 0% 153 $0.00
82009 0% 18 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 13 $0.00
47563 0% 12 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialRAE, KARYN (DIRECTOR)
Same official

Other billing entities under RAE, KARYN

Full network →
ProviderLocationPaid
Medical University Hospital AuthorityCharleston, SC$241.43M
University Medical Associates of the Medical University of South CarolCharleston, SC$56.50M
Medical University Hospital AuthorityCharleston, SC$32.62M
Medical University Hospital AuthorityCharleston, SC$12.42M
University Medical AssociatesCharleston, SC$9.16M
Carolina Family Care, INCLancaster, SC$6.87M
University Medical Associates of the Medical University of South CarolCharleston, SC$6.15M
University Medical Associates of the Medical University of South CarolCharleston, SC$5.38M
Carolina Family Care, INCFlorence, SC$4.06M
University Medical Associates of the Medical University of South CarolCharleston, SC$3.58M
University Medical Associates of the Medical University of South CarolCharleston, SC$3.53M
University Medical Associates of the Medical University of South CarolCharleston, SC$3.34M
University Medical Associates of the Medical University of South CarolCharleston, SC$2.80M
University Medical Associate of the Medical University of South CaroliCharleston, SC$2.30M
University Medical Associates of the Medical University of South CarolCharleston, SC$1.98M
University Medical Associates of the Medical University of South CarolCharleston, SC$1.88M
University Medical Associates of the Medical University of South CarolCharleston, SC$1.79M
University Medical Associates of the Medical University of South CarolCharleston, SC$1.72M
University Medical Associates of the Medical University of South CarolCharleston, SC$1.57M
Carolina Family Care, INCMt Pleasant, SC$1.31M

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.